When excess fat is stored within the liver, it inhibits its ability to function. When a fatty liver isn’t the result of alcohol consumption, then the condition is known as nonalcoholic fatty liver disease (NAFLD). When the condition is severe enough to cause swelling and inflammation of the liver, it can lead to nonalcoholic steatohepatitis (NASH) which is associated with liver cancer and can progress to cirrhosis. There is no FDA-approved treatment for NASH, and NAFLD patients with advanced fibrosis are at an increased risk of succumbing to cardiovascular disease as well as cancer related mortality.
Our NASH diagnosis CME and CE as well as NAFLD CME and CE courses are designed to assist medical professionals in their efforts to diagnose and treat patients suffering from these increasingly prevalent conditions.